NEW DELHI: Today, 24th Feb, The Supreme Court of India strongly addressed the issue of misleading advertisements in the medical field, particularly those targeting allopathic medicine. The Court is hearing a plea filed by the Indian Medical Association (IMA) against such deceptive ads and has stressed the importance of following Rule 170 of the Drugs and Cosmetics Rules, 1945.
Today, On 15th January, The Supreme Court closed the contempt case against Dr. RV Asokan, President of the Indian Medical Association (IMA), for making contemptuous remarks about the court. These comments were made during a press interview while the IMA’s plea against Patanjali Ayurved, regarding misleading advertisements, was still pending. The court found no reason to proceed further with the case. Dr. Asokan had criticized the court’s actions in the ongoing legal matter.
The Union Government mandates a self-declaration certificate for advertisers as per a Supreme Court order, requiring it for all new ads starting June 18, 2024. The certificate ensures ad compliance with regulations and prevents misleading claims. Advertisers must upload the certificate via specified portals, with existing ads exempt from this requirement.
